Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal

Tropical Doctor

Volumn 37, Issue 3, 2007, Pages 162-163

  Pandey, B ^a   Shrestha, K ^a   Lewis, J ^a   Hawksworth, R A ^a,b   Walker, S L ^a  

^a Anandaban Leprosy Hospital   (Nepal)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; LEPROSTATIC AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG COMBINATION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; LEPROSY; MALE; MIDDLE AGED; MORTALITY; NEPAL; CLINICAL FEATURE; DRESS SYNDROME; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIBACILLARY LEPROSY; OUTCOME ASSESSMENT; PAUCIBACILLARY LEPROSY; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; DAPSONE; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MIDDLE AGED; NEPAL;

EID: 35248817869     PISSN: 00494755     EISSN: None     Source Type: Journal    
DOI: 10.1258/004947507781524700     Document Type: Article

References (8)

1. World Health Organisation. Chemotherapy of Leprosy for Control Programmes. Geneva: WHO, 1982. Tech Rep Ser 675
2. Global leprosy situation, 2005. Wkly Epidemiol Rec 2005;80:289–295
3. Jacobson RR. Treatment of leprosy. In: Hastings RC, ed. Leprosy. 2nd edn. Edinburgh: Churchill Livingstone, 1994: 317–349
4. Lowe J, Smith M. Chemotherapy of leprosy in Nigeria. Int J Lepr 1949;17:181–195
5. Allday E, Barnes J. Toxic effects of diaminodiphenylsulphone in treatment of leprosy. Lancet 1951;ii:205–266
6. Smith WSC. Are hypersensitivity reactions to dapsone becoming more frequent? Lep Rev 1989;59:53–58
7. Richardus JH, Smith TC. Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy. Lepr Rev 1989;60:267–273
8. Narasimha Rao P, Lakshmi TS. Increase in the incidence of dapsone hypersensitivity syndrome - an appraisal. Lepr Rev 2001;72:57–62